Global Injectable Drug Delivery Formulation Market Survey and Trend Research 2018

September 2018 | 72 pages | ID: GEF99367194EN
99Strategy

Abstracts

Summary


This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Becton, Dickinson and Company (U.S.), Baxter International Inc. (U.S.), Gerresheimer AG (Germany), Pfizer, Inc. (U.S.), Sandoz (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (U.S.) etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Injectable Drug Delivery Formulation Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 INJECTABLE DRUG DELIVERY FORMULATION MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Becton, Dickinson and Company (U.S.) (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Baxter International Inc. (U.S.) (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Gerresheimer AG (Germany) (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Pfizer, Inc. (U.S.) (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Sandoz (Germany) (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Sandoz (Germany) (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Teva Pharmaceutical Industries Ltd. (Israel) (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Eli Lilly and Company (U.S.) (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Injectable Drug Delivery Formulation Market 2012-2017, by Type, in USD Million
Table Global Injectable Drug Delivery Formulation Market 2012-2017, by Type, in Volume
Table Global Injectable Drug Delivery Formulation Market Forecast 2018-2023, by Type, in USD Million
Table Global Injectable Drug Delivery Formulation Market Forecast 2018-2023, by Type, in Volume
Table Becton, Dickinson and Company (U.S.) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Becton, Dickinson and Company (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxter International Inc. (U.S.) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Baxter International Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gerresheimer AG (Germany) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Gerresheimer AG (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. (U.S.) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Pfizer, Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz (Germany) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Sandoz (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz (Germany) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Sandoz (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. (Israel) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Teva Pharmaceutical Industries Ltd. (Israel) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company (U.S.) Overview List
Table Injectable Drug Delivery Formulation Business Operation of Eli Lilly and Company (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Injectable Drug Delivery Formulation Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Injectable Drug Delivery Formulation Sales Revenue Share, by Companies, in USD Million
Table Global Injectable Drug Delivery Formulation Sales Volume 2012-2017, by Companies, in Volume
Table Global Injectable Drug Delivery Formulation Sales Revenue Share, by Companies in 2017, in Volume
Table Injectable Drug Delivery Formulation Demand 2012-2017, by Application, in USD Million
Table Injectable Drug Delivery Formulation Demand 2012-2017, by Application, in Volume
Table Injectable Drug Delivery Formulation Demand Forecast 2018-2023, by Application, in USD Million
Table Injectable Drug Delivery Formulation Demand Forecast 2018-2023, by Application, in Volume
Table Global Injectable Drug Delivery Formulation Market 2012-2017, by Region, in USD Million
Table Global Injectable Drug Delivery Formulation Market 2012-2017, by Region, in Volume
Table Injectable Drug Delivery Formulation Market Forecast 2018-2023, by Region, in USD Million
Table Injectable Drug Delivery Formulation Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Injectable Drug Delivery Formulation Industry Chain Structure
Figure Global Injectable Drug Delivery Formulation Market Growth 2012-2017, by Type, in USD Million
Figure Global Injectable Drug Delivery Formulation Market Growth 2012-2017, by Type, in Volume
Figure Global Injectable Drug Delivery Formulation Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Injectable Drug Delivery Formulation Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region